Main Line Health account plan
Healthcare services and employment
At a glance
Main Line Health is a nonprofit four-hospital system in suburban Philadelphia with $2,623,980 thousand of FY2025 revenue and 14,000 staff.
Main Line Health System is a nonprofit health system serving Southeastern Pennsylvania, mainly Chester, Delaware and Montgomery Counties. It runs The Bryn Mawr Hospital, The Lankenau Hospital (Lankenau Medical Center), Paoli Hospital, Riddle Memorial Hospital, Bryn Mawr Rehabilitation Hospital, the Mirmont addiction treatment center, the Main Line HealthCare physician network and the Lankenau Institute for Medical Research. In the fiscal year ended June 30, 2025, total revenues, gains and other support were $2,623,980 thousand, of which net patient service revenue was $2,514,150 thousand, and operating income was $4,034 thousand after a FY2024 operating loss of $61,062 thousand. The CEO cites 14,000 nurses, technicians and support staff plus "well over 1,000 physicians". Edward Jimenez became president and CEO in 2025, succeeding Jack Lynch after 20 years.
Business units
Main Line Hospitals, Inc.
Operates The Bryn Mawr Hospital, The Lankenau Hospital (Lankenau Medical Center), Paoli Hospital and Bryn Mawr Rehabilitation Hospital, the core of the system's patient revenue. Bond issues have financed construction and equipment at Bryn Mawr Hospital and Lankenau Medical Center.
Riddle Memorial Hospital
A separate acute hospital in Delaware County, funded in part by the $132,440,000 2020A bonds. Since the Crozer Health closure it has seen more emergency department patients and more births.
Mirmont Alcohol Rehabilitation Center
The system's behavioral health and addiction treatment entity, a member of the bond Obligated Group.
Main Line HealthCare
The physician and primary care arm, paid on established fee schedules. The CEO wants to improve the availability of physician services and hire more doctors to shorten specialist waits.
Lankenau Institute for Medical Research
$1,762,241 of federal research expenditures in FY2025The research entity, funded by National Institutes of Health grants in oral diseases, cancer biology, diabetes, musculoskeletal and cardiovascular research. Net assets restricted to fellowship and research total $152,009 thousand.
Affiliated Foundations
$743,156 thousand of assets at June 30, 2025Separately incorporated foundations for each hospital, whose assets are not pledged to the bonds. The endowment counts about 230 funds and stood at $326,470 thousand.
Joint ventures and surgical affiliates
Includes the 75%-owned 120 Valley Green Lane ambulatory center in King of Prussia, Bryn Mawr Surgery Center (51%), MLJH (50%) with stakes in Physician's Care Surgical Hospital and PhyCare ASC in Royersford, and a 24.5% stake in the DVACO-2 accountable care organization.
Insurance captives
50% stakes in Mountain Laurel Risk Retention Group, which provides primary professional and general liability cover, and in Five Pointe Professional Liability Insurance Company, which reinsures it.
Strategic priorities
- Bring care closer to communities
- The CEO plans to accelerate the opening of community clinics and combine telehealth with easier face-to-face visits, while not reducing services or programs.
- Keep complex care in the suburbs
- Main Line aims to keep patients who now go to Philadelphia's academic medical centers, with most cancer care and cardiac surgery named as growth areas; transplants are out of scope.
- More physicians and shorter waits
- Hiring more doctors and improving the availability of physician services are the main access moves, tied to managing the overall expense platform.
- Return to profitability
- After several years of losses, FY2025 was close to break-even with $4,034 thousand of operating income, and the budget for the year starting July 1, 2025 calls for a modest profit.
- Safety and quality first
- All acute care hospitals earned an A grade from The Leapfrog Group in spring 2025, and the CEO puts patient safety and quality at the top of his priorities.
Latest results
In the fiscal year ended June 30, 2025, total revenues, gains and other support rose to $2,623,980 thousand from $2,393,376 thousand, and net patient service revenue to $2,514,150 thousand from $2,292,290 thousand. Total expenses were $2,611,126 thousand, giving operating income of $4,034 thousand after $8,637 thousand of employee termination costs, against an operating loss of $61,062 thousand in FY2024. A change in estimated useful lives cut depreciation by about $37,500,000. Non-operating investment income of $130,809 thousand lifted the excess of revenues over expenses to $139,023 thousand. No guidance is published beyond a modest budgeted profit for FY2026.
Investments and deals
- Outpatient sites and clinics
- A large outpatient clinic is in planning near Downingtown, and the 73-acre St. Charles Borromeo Seminary campus in Wynnewood, bought in 2019 for $43.5 million, awaits approval for a plan including medical offices.
- Capital spending
- Additions to property and equipment were $104,342 thousand in FY2025 (FY2024: $112,278 thousand), with $84,485 thousand of construction in progress at year end.
- Refinancing and liquidity
- On December 20, 2024 Main Line issued $46,200,000 of Series 2024 bonds to refund the 2015 bonds and signed a $100,000,000 revolving credit agreement, undrawn at June 30, 2025.
Challenges and risks
- Cost growth
- Salaries and outside fees reached $1,283,850 thousand, supplies $433,771 thousand and professional services $226,781 thousand in FY2025; the CEO describes "an expenditure challenge that the organization couldn't keep up with".
- Competition from city academic centers
- Patients are pulled toward the Hospital of the University of Pennsylvania and Thomas Jefferson University Hospital, and ChristianaCare is developing three micro-hospitals in Delaware and Chester Counties.
- Pension and liability exposure
- The pension plan moved to a $6,010 thousand deficit from a $26,657 thousand surplus, with about $50,400,000 of contributions expected in FY2026; accrued professional liability claims were about $296,815,000.
- Government payer shortfalls
- Medical Assistance costs exceeded reimbursement by $50,781,000 in FY2025, and Medicare and Medicaid rules carry fine, penalty and settlement risk.
What leadership says
“We're going to bring care closer to the communities where our patients live.”
“As I come aboard, I see nothing, really, but expansion.”
“We're not going to do transplants, and we're not going to do bone marrow transplants, but most cancer care can happen on the Main Line.”
Where a supplier can help
- Outpatient and clinic build-out
- The push to open more community clinics, the Downingtown outpatient project and the Wynnewood campus create needs for design, construction, equipment and clinic operations partners.
- Telehealth and patient access
- Combining telehealth with easier in-person visits to shorten waits points to scheduling, virtual care and patient engagement tools.
- Cost control in supplies and services
- With supplies and professional services costs rising and expense management a stated focus, procurement, supply chain and revenue cycle vendors that lower cost per case have a clear opening.
- Physician recruiting
- Plans to hire more doctors and expand cancer and cardiac care fit physician recruitment, credentialing and onboarding services.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Main Line Health?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Main Line Health System and Affiliates - Audited Consolidated Financial Statements and Uniform Guidance Report, FY ended June 30, 2025
- Main Line Health System (MLHS) is a nonprofit health system in Southeastern Pennsylvania: the parent of Main Line Hospitals, Inc. (The Bryn Mawr Hospital, The Lankenau Hospital, Paoli Hospital, Bryn Mawr Rehabilitation Hospital), Riddle Memorial Hospital, Mirmont Alcohol Rehabilitation Center, Main Line HealthCare and other entities; it publishes no annual report beyond these audited statements (PwC, unmodified opinion dated October 10, 2025).
- FY ended June 30, 2025: total revenues, gains and other support of $2,623,980 thousand (FY2024: $2,393,376 thousand), of which net patient service revenue $2,514,150 thousand (FY2024: $2,292,290 thousand).
- Operating income of $4,034 thousand after a FY2024 operating loss of $61,062 thousand; operating income before non-recurring charges was $12,854 thousand, after $8,637 thousand of employee termination costs.
- Excess of revenues over expenses (the performance indicator) of $139,023 thousand, driven by $130,809 thousand of non-operating investment income; net assets rose to $3,433,991 thousand on total assets of $4,796,154 thousand.
- Cost pressure: salaries and outside fees $1,283,850 thousand, supplies $433,771 thousand, professional services $226,781 thousand (up from $193,330 thousand); total expenses $2,611,126 thousand. A change in estimated useful lives cut depreciation by about $37,500,000.
- Payor mix (inpatient FY2025): Medicare 26.9%, Independence Blue Cross 21.8%, Aetna 16.0%, Highmark 11.0% (up from 5.9%), Medicaid 1.3%, managed care and other 23.0%.
- Balance sheet: long-term debt $606,579 thousand before current installments and financing costs; $46,200,000 Series 2024 bonds refunded the 2015 bonds; a new $100,000,000 revolving credit agreement (December 20, 2024) was undrawn at year end. Capex (additions to property and equipment) $104,342 thousand.
- Risks flagged: pension plan moved from a $26,657 thousand surplus to a $6,010 thousand deficit (PBO $1,527,183 thousand); accrued professional liability claims of about $296,815,000; Medicaid costs exceeded reimbursement by $50,781,000; Medicare/Medicaid regulatory and settlement risk.
- Main Line Health's new CEO embraces 'great responsibility' (Chief Healthcare Executive)
- Edward Jimenez took over as president and CEO of Main Line Health in June 2025, succeeding Jack Lynch after 20 years; he previously led University Hospital in Newark and UF Health's Shands Hospital.
- He frames his job as continuity: "My job here is not to dramatically alter what he's done."
- No service or program cuts planned; growth through more community sites, telehealth and better physician availability: "We're going to bring care closer to the communities where our patients live."
- Diagnosis of the losses: post-Covid expenses for staff, supplies and medication outpaced the system: "We just have an expenditure challenge that the organization couldn't keep up with."
- No further staff reductions planned after nearly 200 administrative layoffs in January 2025: "As I come aboard, I see nothing, really, but expansion."
- Workforce of 14,000 plus well over 1,000 physicians; he claims "zero problems" recruiting doctors and nurses and strong retention.
- The Crozer Health closure has pushed volume to Riddle Hospital (ER visits, births) and to Lankenau and Bryn Mawr; Main Line hired Crozer nurses, obstetricians and other staff.
- Patient safety and quality are his first priority; all four acute hospitals earned an A grade from The Leapfrog Group in spring 2025.
- Main Line Health's new CEO Ed Jimenez talks about community and growth opportunities (The Philadelphia Inquirer)
- Interview with The Philadelphia Inquirer a month into Ed Jimenez's tenure as CEO of the four-hospital nonprofit, which was finishing a break-even fiscal year after several years of steep losses since COVID-19.
- The budget for the year that started July 1 calls for a modest profit; Jimenez sees a road map back to the strong profitability the system was long known for.
- Main growth lever: keep suburban patients from going to Philadelphia's academic centers (Penn, Jefferson), an opportunity a BCG analysis for Main Line also identified.
- Service-line focus: "most cancer care can happen on the Main Line"; cardiac surgery is another growth area; no transplants or bone marrow transplants.
- Access: six outpatient facilities today; hiring more doctors to shorten specialist waits; a large outpatient clinic planned near Downingtown.
- Real estate: the 73-acre St. Charles Borromeo Seminary campus in Wynnewood, bought in 2019 for $43.5 million, awaits Lower Merion approval for a plan including medical offices.
- He downplays ChristianaCare winning the Crozer outpatient leases, saying Main Line would have had overcapacity in Glen Mills.
Questions about Main Line Health
What does Main Line Health do?
Main Line Health is a nonprofit health system providing inpatient, outpatient, emergency, rehabilitation, behavioral health, home care and physician services, principally to residents of Southeastern Pennsylvania through four acute care hospitals and a rehabilitation hospital.
What is Main Line Health's revenue?
In the fiscal year ended June 30, 2025, total revenues, gains and other support were $2,623,980 thousand, with operating income of $4,034 thousand.
How many employees does Main Line Health have?
The CEO cites 14,000 nurses, technicians, housekeepers, dietary and other staff, plus well over 1,000 physicians.
Who leads Main Line Health?
Edward Jimenez has been president and CEO since 2025, succeeding Jack Lynch, who led the system for 20 years.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)